In this regard, resveratrol is proposed to decrease the level of matrix metalloproteinases in patients receiving delayed recombinant tissue plasminogen activator treatment, resulting in a better post-stroke outcome (Chen et al., 2016). Here, PLAT is linked to stroke disorder.